Our current products include MDCL Streamline (diabetes hospital clinic application) and our Diabetes Retinopathy Artificial Intelligence analysis model. We can deliver both standalone windows desktop applications and full stack browser based solutions for hospital clinics such as diabetes in bespoke or reconfigurable formats.

Our primary goal is to provide data analytics for the healthcare sector in the form of SaMD and to ultimately deliver a predictive analytics product that will enable healthcare professionals to act preventatively before minor illness become seriosserious.

A major endeavour of our company is to build the cornerstone applications that will empower and facilitate patients to better manage and improve their conditions.

We have jointly presented a poster at the Irish Endocrine Society 2019 and more recently published a diabetes retinopathy poster in conjunction with the nimbus research center.

The ROSIA-PCP project very much aligns with the progress we wish achieve and that path to progression we wish to fulfil as a company.

Our primary focus is medical data management, analysis, usage and storage. We have expertise in diabetes clinic management, integration, machine learning and user experience design.

Our CMO, Fíona O’Ciobhaín, has over 18 years’ experience in the patient rehabilitation sector and we are now focussing on end user testing specifically in the area of people with disabilities and patients currently in rehabilitation programs.

Expectations:

• In the context of this collaborative project, we are looking toward solutions providers like ourselves and especially those that have delivered Software as a Medical Device (SaMD) solutions.
• As a micro company MDCL, we are hoping to find a larger company with a similar corporate value system with whom we can align to form a consortium to deliver a tele rehabilitation solution that offers real benefits to the end users.

Health Insight Solutions GmbH (HIS) is the daughter company of an experienced eHealth advisory company based in Brussels. Health Insight Solutions GmbH (HIS) is dedicated exclusively to the development sales and deployment of telehealth and telecare solutions. Its clients are health- and social care providers

We are specialised in platform for the telemonitoring of frail individuals (older people, chronic patients, people in rehabilitation after an hospitalisation episode). We have started our activities in 2007 and our systems Health Insight Solutions GmbH have been installed in 14 European countries.

Since 2008, we are the suppliers of telemonitoring solutions to the Barbastro Health Sector in Aragon which is one of the ROSIA pilot sites.

Expectations:

• We would like to be part of a consortium which values our long-term relationship with the Barbastro Health Sector and our understanding of the local context there. Our interest in the project making our telemonitoring platform ROSIA-compliant and to integrate it with disease-specific devices and apps.
• We can also support the coordinator with our PCP experience having already participated as Lead Supplier in five PCP tenders, three of which have been successful.
• In the case of ROSIA we have discarded the idea of leading again a consortium because we lack competence in too many areas relevant for the project.
• If requested, we can also provide competence in change management in the care field and in impact evaluation of Technology Enabled Care interventions, either directly or through organisation we have a close relationship with.

McCormick Northburgh has conducted several focus groups with a ‘looks like, feels like’ prototype and has received overwhelmingly positive feedback. This project involves a physical product for individuals with weak hand grip, limited dexterity and disabilities that affect hand function (stroke, MS, TBI etc.).

There are 2 aspects to McCormick Northburgh the device:

1) rehabilitation,

2) self management of their condition at home for food preparation.

We want partners to compliment our team and help develop the concept, considering human factors and the usability of the device in order to develop the device.

Product Design, Mechanical Design, Manufacturing, Design for Manufacture, Medical Devices, Physical Products.

Expectations:

• Textile Material Selection, Polymer Material Selection, Rapid Prototyping, Concept Development, Human Factors.

Digital PAD Test will be a novel patented method for measuring Stress Incontinence for use by clinicians. The alpha device is under development with a Dublin University.

This Digital PAD Test device will be used in clinical settings and potentially for use at home to measure scale of Incontinence and improvements while using medication.

Developing Smart Diagnostic for measuring stress incontinence.

Expectations:

• Looking for Telemedicine, AI app development.